Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02538523 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effect of Low Level Laser Light on Low Back Pain
A NA study, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02538523 is a NA study that has completed, run by Erchonia Corporation. The registered enrollment target is 58 participants.
The verdict
NCT02538523, a NA study, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This study evaluates the effect of low level laser light therapy on reducing low back pain. Half of the participants will receive the actual treatment with the active laser and the other half of the participants will receive a placebo treatment with an inactive laser.
Interventions
- DEVICE Placebo Laser
- DEVICE Erchonia FX-635
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-04-08 |
| Est. Completion | 2017-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02538523
The ClinicalTrials.gov registry entry for NCT02538523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Laser is the first listed.
NCT02538523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02538523 about?
NCT02538523 is a clinical study titled "A Study to Evaluate the Effect of Low Level Laser Light on Low Back Pain". This study evaluates the effect of low level laser light therapy on reducing low back pain. Half of the participants will receive the actual treatment with the active laser and the other half of the participants will receive a placebo treatment with an inactive laser.
What is the current status of trial NCT02538523?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2016-04-08. Estimated completion is 2017-12-10.
What interventions are being tested in trial NCT02538523?
The interventions under investigation include: Placebo Laser (DEVICE), Erchonia FX-635 (DEVICE).
Who is sponsoring clinical trial NCT02538523?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.